Imiquimod in dermatology: an overview
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Imiquimod is an immune response modifier commercially available as a 3.75 and 5% cream. Topical imiquimod stimulates the innate and adaptive immune responses and induces cytokine production. This allows its use for the treatment of a wide variety of benign and malignant skin conditions due to its potential antiviral, antitumor, and immunoregulatory effects. Currently, topical imiquimod is US Food and Drug Administration (FDA)‐approved for the treatment of anogenital warts, actinic keratosis, and superficial basal cell carcinomas. However, it has also shown a beneficial effect in the treatment of many other skin disorders. In this review, we describe existing evidence on the mechanism of action of topical imiquimod, its FDA‐approved indications, off‐label uses, and side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexually Transmitted Diseases Treatment Guidelines, 2006
Skolnik, N. S. (2007) · Current Clinical Practice · doi:10.1007/978-1-59745-313-4_17 · Cited by 3,124
Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 766
Geisse, J., Caro, I., Lindholm, J., Golitz, L., Stampone, P., & Owens, M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.11.066 · Cited by 505
Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug
Miller, R. L., Gerster, J. F., Owens, M. L., Slade, H. B., & Tomai, M. A. (1999) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(98)00068-x · Cited by 417
Topical treatments for cutaneous warts
Kwok, C. S., Gibbs, S., Bennett, C., Holland, R., & Abbott, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001781.pub3 · Cited by 388
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells
Stary, G., Bangert, C., Tauber, M., Strohal, R., Kopp, T., & Stingl, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070021 · Cited by 363
Interventions for basal cell carcinoma of the skin
Bath-Hextall, F. J., Perkins, W., Bong, J., & Williams, H. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003412.pub2 · Cited by 357
Marks, R., Gebauer, K., Shumack, S., Amies, M., Bryden, J., Fox, T. L., & Owens, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.113689 · Cited by 333
Treatment of genital warts with an immune-response modifier (imiquimod)
Beutner, K. R., Spruance, S. L., Hougham, A. J., Fox, T. L., Owens, M. L., & Douglas, J. M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70243-9 · Cited by 299
Lebwohl, M., Dinehart, S., Whiting, D., Lee, P. K., Tawfik, N., Jorizzo, J., Lee, J. H., & Fox, T. L. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.12.010 · Cited by 293
Cited by
Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics
Xu, C., Huang, J., Jiang, Y., He, S., Zhang, C., & Pu, K. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00978-z · Cited by 267
Cosmetic and Therapeutic Applications of Fish Oil’s Fatty Acids on the Skin
Huang, T.-H., Wang, P.-W., Yang, S.-C., Chou, W.-L., & Fang, J.-Y. (2018) · Marine Drugs · doi:10.3390/md16080256 · Cited by 210
“Imiquimod is a toll-like receptor 7/8 agonist prescribed as a topical drug for treating actinic keratosis, skin warts, and malignancy [69].”
BackgroundPharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183
Sunlight, Vitamin D, and Xeroderma Pigmentosum
Martens, M. C., Emmert, S., & Boeckmann, L. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-46227-7_16 · Cited by 24
Metadata
- Authors
- Hanna, E., Abadi, R., & Abbas, O.
- Venue
- International Journal of Dermatology
- Publisher
- Wiley
- Published
- 2016-07-08
- Volume
- 55
- Issue
- 8
- Pages
- 831-844
- ISSN
- 0011-9059 (ISSN-L)
- 1365-4632
- OpenAlex
- W2468627168
- Cited by
- 215
- References
- 67
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imiquimod in dermatology: an overview. https://app.cochat.ai/papers/10.1111/ijd.13235
- The paper
- Hanna, E., Abadi, R., & Abbas, O. (2016). Imiquimod in dermatology: an overview. International Journal of Dermatology. https://doi.org/10.1111/ijd.13235
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.